RIPK2 Stabilizes c-Myc and is an Actionable Target for Inhibiting Prostate Cancer Metastasis
Y. Yan, B. Zhou, C. Qian, A. Vasquez, A. Chatterjee, X. Yuan, E. Posadas, N. Kyprianou, B. S. Knudsen, R. Murali, A. Gertych, S. You, M. R. Freeman, W. Yang
This study identifies RIPK2 as a target for inhibiting prostate cancer metastasis by stabilizing c-Myc and shows its suppression reduces disease progression.
bioRxiv · May 14, 2020Cancer Biology